@article{3107610,
    title = "Reply to the letter to the editor 'Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies'",
    author = "Cherny, N.I. and Dafni, U. and Bogaerts, J. and Latino, N.J. and Pentheroudakis, G. and Douillard, J.-Y. and Tabernero, J. and Zielinski, C. and Piccart, M.J. and de Vries, E.G.E.",
    journal = "Annals of Oncology",
    year = "2018",
    volume = "29",
    number = "3",
    pages = "774-775",
    publisher = "Oxford University Press",
    issn = "0923-7534, 1569-8041",
    doi = "10.1093/annonc/mdx747",
    keywords = "biomedical technology assessment;  cancer therapy;  clinical effectiveness;  conceptual framework;  health care policy;  health care system;  human;  Letter;  palliative therapy;  patient decision making;  practice guideline;  priority journal;  reimbursement;  neoplasm;  oncology, Humans;  Medical Oncology;  Neoplasms"
}